Schizophrenia Research
Volume 58, Issue 1 , Pages 11-20 , 1 November 2002

Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study

  • Marquis P Vawter

      Affiliations

    • Cellular Neurobiology Research Branch, National Institute on Drug Abuse, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA
    • Psychiatry and Human Behavior, University of California, Irvine, CA 92697-1675, USA
    • Tel.:+1-949-824-9014; fax: +1-949-824-7012
    • ,
  • Jeremy M Crook

      Affiliations

    • Clinical Brain Disorders Branch, National Institute of Mental Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    • ,
  • Thomas M Hyde

      Affiliations

    • Clinical Brain Disorders Branch, National Institute of Mental Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    • ,
  • Joel E Kleinman

      Affiliations

    • Clinical Brain Disorders Branch, National Institute of Mental Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    • ,
  • Daniel R Weinberger

      Affiliations

    • Clinical Brain Disorders Branch, National Institute of Mental Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    • ,
  • Kevin G Becker

      Affiliations

    • DNA Array Unit, Research Resources Branch, National Institute on Aging, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA
    • ,
  • William J Freed

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-410-550-1405, fax: +1-410-550-1621
    • Cellular Neurobiology Research Branch, National Institute on Drug Abuse, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA

Received 21 March 2001 ,Revised 4 October 2001 ,Accepted 9 October 2001.

References 

  1. Baron M. Genetics of schizophrenia and the new millennium: progress and pitfalls. Am. J. Hum. Genet. 2001;68:299–312
  2. Barrett T, Cheadle C, Wong WH, Teichberg D, Donovan DM, Freed WJ, et al. Assembly and use of a broadly applicable neural cDNA microarray. Restor. Neurol. Neurosci. 2001;18:127–135
  3. Becher B, Barker PA, Owens T, Antel JP. CD95–CD95L: can the brain learn from the immune system?. Trends Neurosci. 1998;21:114–117
  4. Brenner C, Bieganowski P, Pace HC, Huebner K. The histidine triad superfamily of nucleotide-binding proteins. J. Cell. Physiol. 1999;181:179–187
  5. Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Mol. Brain Res. 1995;29:211–223
  6. Eastwood SL, Porter RH, Harrison PJ. The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain. Neurosci. Lett. 1996;212:163–166
  7. Eastwood SL, Kerwin RW, Harrison PJ. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-d-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol. Psychiatry. 1997;41:636–643
  8. Freed WJ. An hypothesis regarding the antipsychotic effect of neuroleptic drugs. Pharmacol. Biochem. Behav. 1989;32:337–345
  9. Freed WJ, Dillon-Carter O, Kleinman JE. Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide. Exp. Neurol. 1993;121:48–56
  10. Gamble SC, Dunn MJ, Wheeler CH, Joiner MC, Adu-Poku A, Arrand JE. Expression of proteins coincident with inducible radioprotection in human lung epithelial cells. Cancer Res. 2000;60:2146–2151
  11. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. Ionotropic glutamate receptors and expression of N-methyl-d-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am. J. Psychiatry. 2000;157:1141–1149
  12. Gilmour J, Liang N, Lowenstein JM. Isolation, cloning and characterization of a low-molecular-mass purine nucleoside-and nucleotide-binding protein. Biochem. J. 1997;326:1–7
  13. Hakak Y, Walker JR, Li C, Wong WH, David KL, Buxbaum JD, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2001;98:4746–4751
  14. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 1999;122:593–624
  15. Healy DJ, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ, et al. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neuropsychopharmacology. 1998;19:278–286
  16. Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 2001;276:4588–4596
  17. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 1996;379:349–353
  18. Meador-Woodruff JH, Healy DJ. Glutamate receptor expression in schizophrenic brain. Brain Res. Rev. 2000;31:288–294
  19. Mielke K, Herdegen T. JNK and p38 stresskinases-degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol. 2000;61:45–60
  20. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 2000;28:53–67
  21. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry. 2001;6:293–301
  22. Spurney CF, Baca SM, Murray AM, Jaskiw GE, Kleinman JE, Hyde TM. Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats. Synapse. 1999;34:266–276
  23. Stillman BA, Tonkinson JL. Expression microarray hybridization kinetics depend on length of the immobilized DNA but are independent of immobilization substrate. Anal. Biochem. 2001;295:149–157
  24. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. Support for a possible schizophrenia vulnerability locus in region 5q22–31 in Irish families. Mol. Psychiatry. 1997;2:148–155
  25. Tan Z, Qu W, Tu W, Liu W, Baudry M, Schreiber SS. p53 accumulation due to down-regulation of ubiquitin: relevance for neuronal apoptosis. Cell Death Differ. 2000;7:675–681
  26. Vawter MP, Barrett T, Cheadle C, Sokolov B, Wood W, Donovan DM, et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 2001;55:641–650
  27. Whitney LW, Becker KG, Tresser NJ, Caballero-Ramos CI, Munson PJ, Prabhu VV, et al. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 1999;46:425–428

PII: S0920-9964(01)00377-2

Schizophrenia Research
Volume 58, Issue 1 , Pages 11-20 , 1 November 2002

Article Tools

* Image Usage & Resolution